α-Conotoxin ImI is a disulfide-rich, cysteine-constrained peptide from cone snail venom targeting nicotinic receptor subtypes in research settings. Its compact fold and defined loop architecture enable high-affinity binding. Researchers examine structure-activity relationships via NMR and mutagenesis. Applications include ion-channel mapping, neurotoxin motif analysis, and conformational-stability studies.
CAT No: PI-024
CAS No:156467-85-5
Synonyms/Alias:alpha-Conotoxin imi;alpha-Ctx-imi;156467-85-5;Gly-cys-cys-ser-asp-pro-arg-cys-ala-trp-arg-cys-NH2;DTXSID10166085;Glycyl-cysteinyl-cysteinyl-seryl-asparginyl-prolyl-arginyl-cysteinyl-alanyl-tryptophyl-arginyl-cysteinamide;L-Cysteinamide, glycyl-L-cysteinyl-L-cysteinyl-L-seryl-L-alpha-aspartyl-L-prolyl-L-arginyl-L-cysteinyl-L-alanyl-L-tryptophyl-L-arginyl-, cyclic (2-8),(3-12)-bis(disulfide);alpha-CTX IMI;CHEMBL500076;DTXCID7088576;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.